Log In
Print
BCIQ
Print
Print this Print this
 

ceftazidime/avibactam (CAZ AVI, CAZ-104, CAZ104) (formerly NXL104/ceftazidime)

  Manage Alerts
Collapse Summary General Information
Company AstraZeneca plc
DescriptionBroad spectrum beta lactamase (LACTB) inhibitor combined with ceftazidime, a third-generation cephalosporin
Molecular Target Beta lactamase (LACTB)
Mechanism of ActionBeta lactamase inhibitor
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today